Calimpong, Virgilio L.

HRN: 21-66-69  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/19/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/19/2026
08/26/2026
IV
2.25g
Q8H
Non-healing Wound
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: